Literature DB >> 29672311

Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set.

Antonio Benito Porcaro1, Alessandro Tafuri1, Giovanni Novella1, Marco Sebben1, Arianna Mariotto1, Davide Inverardi1, Paolo Corsi1, Tania Processali1, Marco Pirozzi1, Nelia Amigoni1, Riccardo Rizzetto1, Matteo Brunelli2, Matteo Balzarro1, Salvatore Siracusano1, Walter Artibani1.   

Abstract

OBJECTIVES: The study aimed to evaluate associations of prostatic chronic inflammation (PCI) with prostate cancer (PCA) grade groups by the International Society of Urological Pathology (ISUP).
METHODS: The study evaluated retrospectively 738 cases. The patient population was sampled into 3 groups collecting cases without and with PCA including subjects with lSUP grade group 1 and grade groups 2-5.
RESULTS: PCI was assessed in 185 patients (25.1%) and PCA in 361 patients (48.9%) of whom 188 (25.5%) had ISUP grade and 173 (23.4%) had ISUP groups 2-5 tumors. PCI inversely related to ISUP groups (p < 0.0001). In multivariate analysis, the risk of ISUP grade group 1 PCA compared to negative cases associated positively with age (OR 1.042; p = 0.001) but inversely with total prostate volume (TPV; OR 0.965; p < 0.0001) and PCI (OR 0.314; p < 0.0001). Intermediate-high grade tumors associated positively with age (OR 1.065; p < 0.0001), prostate specific antigen (OR 1.167; p < 0.0001), and abnormal digital rectal examination (OR 2.251; p < 0.0001) but inversely with TPV (OR 0.921; p < 0.0001) and PCI (OR 0.106; p < 0.0001).
CONCLUSIONS: PCI decreased the risk of PCA among ISUP tumor grade groups.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Prostate biopsy; Prostate cancer; Prostate cancer tumor grade; Prostate-specific antigen; Prostatic chronic inflammation

Mesh:

Substances:

Year:  2018        PMID: 29672311     DOI: 10.1159/000488882

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  3 in total

1.  Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy.

Authors:  Antonio B Porcaro; Alessandro Tafuri; Marco Sebben; Giovanni Novella; Tania Processali; Marco Pirozzi; Nelia Amigoni; Riccardo Rizzetto; Aliasger Shakir; Arianna Mariotto; Matteo Brunelli; Maria Angela Cerruto; Giovanni Enrico Cacciamani; Filippo Migliorini; Salvatore Siracusano; Walter Artibani
Journal:  World J Urol       Date:  2019-06-01       Impact factor: 4.226

2.  Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors.

Authors:  Alessandro Tafuri; Marco Sebben; Giovanni Novella; Marco Pirozzi; Tania Processali; Aliasger Shakir; Riccardo Rizzetto; Nelia Amigoni; Riccardo Bernasconi; Matteo Brunelli; Maria A Cerruto; Salvatore Siracusano; Alessandro Antonelli; Walter Artibani; Antonio B Porcaro
Journal:  Arab J Urol       Date:  2020-05-13

3.  Prostate volume index and prostatic chronic inflammation have an effect on tumor load at baseline random biopsies in patients with normal DRE and PSA values less than 10 ng/ml: results of 564 consecutive cases.

Authors:  Antonio B Porcaro; Alessandro Tafuri; Marco Sebben; Aliasger Shakir; Giovanni Novella; Marco Pirozzi; Tania Processali; Riccardo Rizzetto; Nelia Amigoni; Leone Tiso; Clara Cerrato; Matteo Brunelli; Maria Angela Cerruto; Filippo Migliorini; Salvatore Siracusano; Walter Artibani
Journal:  Ther Adv Urol       Date:  2019-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.